Exercise for Preterm Birth
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore why young adults born very preterm (before 32 weeks) struggle to improve their fitness levels through aerobic exercise. Researchers focus on the mitochondria, the energy producers in cells, and their DNA to understand this issue better. Participants will either undergo a 16-week aerobic exercise program (also referred to as physical activity, workout, or fitness training) or provide samples for mitochondrial DNA analysis. The trial seeks inactive young adults, aged 18-35, who were born preterm or at full term. The goal is to identify potential markers linked to exercise response and heart disease risk in those born preterm. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could improve health outcomes for those born preterm.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this exercise program is safe for young adults born very preterm?
Research shows that aerobic exercise is usually safe and beneficial for most people. Studies have found that physical activity during pregnancy can lead to fewer health issues and better overall well-being. Although these studies focus on pregnant women, they suggest that aerobic exercise is generally well-tolerated by many people.
This trial focuses on young adults born very early, aiming to improve their fitness through aerobic exercise. While specific studies on this exact group are lacking, the general safety of aerobic exercise is reassuring. Similar exercise programs have not reported major problems.
Although more research is needed to understand how this group specifically responds, current evidence suggests that aerobic exercise is a safe way to boost health.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the potential benefits of aerobic exercise as a method to improve outcomes for individuals born prematurely, a group that typically faces various health challenges. Unlike standard treatments for preterm birth, which often involve medical or surgical interventions, this approach focuses on a non-invasive lifestyle modification that could enhance overall health and fitness. Additionally, the trial includes mitochondrial DNA sequencing to uncover genetic variants specific to those born prematurely, which could lead to personalized treatment strategies in the future. This combination of exercise and genetic analysis offers a fresh perspective on managing and understanding the long-term effects of preterm birth.
What evidence suggests that this trial's treatments could be effective for improving fitness in young adults born very preterm?
This trial will compare the effects of aerobic exercise training with mitochondrial DNA sequencing in individuals born prematurely. Research has shown that aerobic exercise greatly benefits health, but young adults born very early often struggle to improve fitness through exercise. This difficulty may stem from mitochondrial problems, as mitochondria function like the power plants of cells. Mitochondrial issues are common in those born preterm and might influence their exercise response. While direct evidence is lacking that exercise can enhance fitness for this group, understanding mitochondrial DNA could lead to better solutions. The goal is to identify specific mitochondrial changes that might improve exercise responses in the future.14678
Are You a Good Fit for This Trial?
This trial is for inactive young adults aged 18-35 who were born preterm (before 37 weeks) and their biological mothers, as well as age- and sex-matched controls born at term. Participants must exercise less than 150 minutes per week and pass a health readiness assessment to start moderate-intensity exercise.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Mitochondrial DNA Sequencing
Participants provide a blood or saliva sample for mitochondrial DNA sequencing analysis to assess for variants unique to individuals born prematurely
Aerobic Exercise Training
Participants complete a 16-week aerobic exercise training program
Follow-up
Participants are monitored for changes in mitochondrial oxidative capacity and maximal aerobic capacity after the training program
What Are the Treatments Tested in This Trial?
Interventions
- Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
Texas Tech University
Lead Sponsor